http://www.unboundmedicine.com/medline/ebm/research/conivaptanUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19885790/full_citation/[Vasopressin_receptor_antagonists_and_heart_failure_]Haass M 
[Vasopressin receptor antagonists and heart failure.] [JOURNAL ARTICLE]
Ther Umsch 2009 Nov; 66(11):735-740.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19790137/full_citation/Conivaptan_increases_serum_sodium_in_hyponatremic_patients_with_end_stage_liver_disease_O'Leary JG, Davis GL 
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. [JOURNAL ARTICLE]
Liver Transpl 2009 Sep 29; 15(10):1325-1329.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19763821/full_citation/Potential_of_endothelin_1_and_vasopressin_antagonists_for_the_treatment_of_congestive_heart_failure_Rehsia NS, Dhalla NS 
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure. [JOURNAL ARTICLE]
Heart Fail Rev 2009 Sep 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19695403/full_citation/Pharmacokinetics_of_conivaptan_hydrochloride_a_vasopressin_V_1A_/V_2__receptor_antagonist_in_patients_with_euvolemic_or_hypervolemic_hyponatremia_and_with_or_without_congestive_heart_failure_from_a_prospective_4_day_open_label_study_Mao ZL, Stalker D, Keirns J 
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study. [Journal Article, Research Support, Non-U.S. Gov't]
Clin Ther 2009 Jul; 31(7):1542-50.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19663609/full_citation/Conivaptan:_promise_of_treatment_in_heart_failure_Hoque MZ, Arumugham P, Huda N, et al. 
Conivaptan: promise of treatment in heart failure. [Journal Article]
Expert Opin Pharmacother 2009 Sep; 10(13):2161-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19557204/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19542534/full_citation/Successful_treatment_of_ifosfamide_induced_hyponatremia_with_AVP_receptor_antagonist_without_interruption_of_hydration_for_prevention_of_hemorrhagic_cystitis_Glezerman IG 
Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis. [Letter]
Ann Oncol 2009 Jul; 20(7):1283-5.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19523576/full_citation/Hyponatremia:_case_vignettes_Mount DB, Krahn TA 
Hyponatremia: case vignettes. [Journal Article]
Semin Nephrol 2009 May; 29(3):300-17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19169014/full_citation/Role_of_Vasopressin_and_Vasopressin_Receptor_Antagonists_in_Type_I_Cardiorenal_Syndrome_Schrier RW, Masoumi A, Elhassan E 
Role of Vasopressin and Vasopressin Receptor Antagonists in Type I Cardiorenal Syndrome. [JOURNAL ARTICLE]
Blood Purif 2009; 27(1):28-32.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19151543/full_citation/New_Topics_in_Vasopressin_Receptors_and_Approach_to_Novel_Drugs:Research_and_Development_of_Conivaptan_Hydrochloride__YM087__a_Drug_for_the_Treatment_of_Hyponatremia_Arai Y, Fujimori A, Sasamata M, et al. 
New Topics in Vasopressin Receptors and Approach to Novel Drugs:Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia. [JOURNAL ARTICLE]
J Pharmacol Sci 2009; 109(1):53-59.
Abstract | Full Citation | Find Related Articles